US Stock MarketDetailed Quotes

Phio Pharmaceuticals (PHIO)

Watchlist
  • 1.190
  • -0.040-3.25%
Close Apr 24 16:00 ET
  • 1.210
  • +0.020+1.68%
Post 19:39 ET
13.82MMarket Cap-0.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Phio Pharmaceuticals (PHIO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.19%-7.98M
-51.64%-2.08M
-6.76%-2.09M
-42.94%-2.54M
36.60%-1.28M
33.84%-7.11M
42.15%-1.37M
32.66%-1.95M
35.87%-1.78M
25.74%-2.01M
Net income from continuing operations
-21.65%-8.7M
-45.82%-2.37M
-56.96%-2.39M
-17.33%-2.17M
17.87%-1.77M
33.96%-7.15M
14.20%-1.63M
45.18%-1.52M
27.58%-1.85M
40.20%-2.15M
Operating gains losses
----
----
----
----
----
---6K
---9K
--0
--0
--3K
Depreciation and amortization
-91.43%3K
--1K
--2K
--0
--0
-80.98%35K
--0
--0
-97.87%1K
-27.66%34K
Change In working capital
270.29%235K
-92.13%17K
139.92%192K
-901.89%-425K
509.46%451K
74.25%-138K
133.08%216K
-87.89%-481K
114.60%53K
-89.95%74K
-Change in prepaid assets
-118.92%-91K
185.83%343K
-318.70%-269K
-63.35%-361K
-57.30%196K
345.41%481K
207.69%120K
164.74%123K
38.44%-221K
46.18%459K
-Change in payables and accrued expense
155.82%326K
-439.58%-326K
176.32%461K
-123.36%-64K
172.86%255K
-184.88%-584K
114.61%96K
-1,787.50%-604K
813.33%274K
-177.09%-350K
-Change in other current liabilities
--0
--0
--0
--0
--0
74.07%-35K
--0
--0
--0
-9.38%-35K
Cash from discontinued investing activities
Operating cash flow
-12.19%-7.98M
-51.64%-2.08M
-6.76%-2.09M
-42.94%-2.54M
36.60%-1.28M
33.84%-7.11M
42.15%-1.37M
32.66%-1.95M
35.87%-1.78M
25.74%-2.01M
Investing cash flow
Cash flow from continuing investing activities
-250.00%-12K
0
-7K
-3K
-2K
260.00%8K
8K
0
0
0
Net PPE purchase and sale
-1,100.00%-12K
--0
---7K
---3K
---2K
80.00%-1K
---1K
--0
--0
--0
Net other investing changes
----
----
----
----
----
--9K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-250.00%-12K
--0
---7K
---3K
---2K
260.00%8K
--8K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
491.59%23.64M
815.50%12.41M
-23.55%2.02M
40K
229,425.00%9.17M
-46.09%4M
-43.61%1.36M
2.65M
0
89.47%-4K
Net common stock issuance
1,791,600.00%17.92M
--9.57M
185,300.00%1.85M
--0
--6.49M
-100.01%-1K
--0
---1K
--0
--0
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
43.80%5.76M
109.07%2.84M
-92.44%200K
--40K
--2.68M
--4M
--1.36M
--2.65M
--0
--0
Net other financing activities
-500.00%-30K
--0
----
----
----
80.77%-5K
0.00%-1K
--0
--0
84.00%-4K
Cash from discontinued financing activities
Financing cash flow
491.59%23.64M
815.50%12.41M
-23.55%2.02M
--40K
229,425.00%9.17M
-46.09%4M
-43.61%1.36M
--2.65M
--0
89.47%-4K
Net cash flow
Beginning cash position
-36.61%5.38M
98.61%10.71M
129.35%10.78M
105.07%13.28M
-36.61%5.38M
-28.24%8.49M
-36.27%5.39M
-58.63%4.7M
-28.73%6.48M
-28.24%8.49M
Current changes in cash
603.51%15.65M
129,175.00%10.33M
-110.12%-70K
-40.86%-2.5M
491.86%7.9M
6.97%-3.11M
-124.24%-8K
123.86%692K
-178.21%-1.78M
26.62%-2.02M
End cash Position
290.77%21.03M
290.77%21.03M
98.61%10.71M
129.35%10.78M
105.07%13.28M
-36.61%5.38M
-36.61%5.38M
-36.27%5.39M
-58.63%4.7M
-28.73%6.48M
Free cash flow
-12.34%-7.99M
-51.53%-2.08M
-7.12%-2.09M
-43.11%-2.54M
36.50%-1.28M
33.86%-7.11M
42.11%-1.37M
32.66%-1.95M
35.99%-1.78M
25.74%-2.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.19%-7.98M-51.64%-2.08M-6.76%-2.09M-42.94%-2.54M36.60%-1.28M33.84%-7.11M42.15%-1.37M32.66%-1.95M35.87%-1.78M25.74%-2.01M
Net income from continuing operations -21.65%-8.7M-45.82%-2.37M-56.96%-2.39M-17.33%-2.17M17.87%-1.77M33.96%-7.15M14.20%-1.63M45.18%-1.52M27.58%-1.85M40.20%-2.15M
Operating gains losses -----------------------6K---9K--0--0--3K
Depreciation and amortization -91.43%3K--1K--2K--0--0-80.98%35K--0--0-97.87%1K-27.66%34K
Change In working capital 270.29%235K-92.13%17K139.92%192K-901.89%-425K509.46%451K74.25%-138K133.08%216K-87.89%-481K114.60%53K-89.95%74K
-Change in prepaid assets -118.92%-91K185.83%343K-318.70%-269K-63.35%-361K-57.30%196K345.41%481K207.69%120K164.74%123K38.44%-221K46.18%459K
-Change in payables and accrued expense 155.82%326K-439.58%-326K176.32%461K-123.36%-64K172.86%255K-184.88%-584K114.61%96K-1,787.50%-604K813.33%274K-177.09%-350K
-Change in other current liabilities --0--0--0--0--074.07%-35K--0--0--0-9.38%-35K
Cash from discontinued investing activities
Operating cash flow -12.19%-7.98M-51.64%-2.08M-6.76%-2.09M-42.94%-2.54M36.60%-1.28M33.84%-7.11M42.15%-1.37M32.66%-1.95M35.87%-1.78M25.74%-2.01M
Investing cash flow
Cash flow from continuing investing activities -250.00%-12K0-7K-3K-2K260.00%8K8K000
Net PPE purchase and sale -1,100.00%-12K--0---7K---3K---2K80.00%-1K---1K--0--0--0
Net other investing changes ----------------------9K----------------
Cash from discontinued investing activities
Investing cash flow -250.00%-12K--0---7K---3K---2K260.00%8K--8K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 491.59%23.64M815.50%12.41M-23.55%2.02M40K229,425.00%9.17M-46.09%4M-43.61%1.36M2.65M089.47%-4K
Net common stock issuance 1,791,600.00%17.92M--9.57M185,300.00%1.85M--0--6.49M-100.01%-1K--0---1K--0--0
Net preferred stock issuance ----------------------0--0--0--0--0
Proceeds from stock option exercised by employees 43.80%5.76M109.07%2.84M-92.44%200K--40K--2.68M--4M--1.36M--2.65M--0--0
Net other financing activities -500.00%-30K--0------------80.77%-5K0.00%-1K--0--084.00%-4K
Cash from discontinued financing activities
Financing cash flow 491.59%23.64M815.50%12.41M-23.55%2.02M--40K229,425.00%9.17M-46.09%4M-43.61%1.36M--2.65M--089.47%-4K
Net cash flow
Beginning cash position -36.61%5.38M98.61%10.71M129.35%10.78M105.07%13.28M-36.61%5.38M-28.24%8.49M-36.27%5.39M-58.63%4.7M-28.73%6.48M-28.24%8.49M
Current changes in cash 603.51%15.65M129,175.00%10.33M-110.12%-70K-40.86%-2.5M491.86%7.9M6.97%-3.11M-124.24%-8K123.86%692K-178.21%-1.78M26.62%-2.02M
End cash Position 290.77%21.03M290.77%21.03M98.61%10.71M129.35%10.78M105.07%13.28M-36.61%5.38M-36.61%5.38M-36.27%5.39M-58.63%4.7M-28.73%6.48M
Free cash flow -12.34%-7.99M-51.53%-2.08M-7.12%-2.09M-43.11%-2.54M36.50%-1.28M33.86%-7.11M42.11%-1.37M32.66%-1.95M35.99%-1.78M25.74%-2.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -